BioSpace News Archive

BIONIK Laboratories InMotion® Robotics Technology Meets the Recovery Demands from an Increase of Stroke Patients Brought on by Severe Cases of COVID-19

BIONIK Laboratories Corp today announced its unique position to meet the increased recovery demands from stroke patients who have suffered from a severe case of COVID-19.

December 17, 2021
·
6 min read
Drug Development

Glycomine Announces First Dosing in Phase 1 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG

Glycomine, Inc. today announced that the company has received U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for GLM101 for the treatment of PMM2-CDG.

December 17, 2021
·
3 min read
Biotech Bay

Guardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR™-2 Blood Test to Detect Colorectal Cancer

Guardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR ™ -2 Blood Test to Detect Colorectal Cancer.

December 17, 2021
·
5 min read
Drug Development

Kineta Presented New Preclinical Data on its Anti-CD27 Agonist Antibody Program at the ESMO Immuno-oncology Congress 2021

Kineta, Inc. announced today the presentation of new preclinical data on the company’s anti-CD27 agonist monoclonal antibody program at the virtual European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2021.

December 17, 2021
·
3 min read
Drug Development

Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis

Bellerophon Therapeutics, Inc. oday announced positive top-line data from a recently completed Phase 2 dose escalation study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse® via right heart catheterization for the treatment of pulmonary hypertension associated with sarcoidosis (PH-Sarc).

December 17, 2021
·
5 min read
Genetown

Karyopharm’s Partner Antengene Receives Approval in China for XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that its partner, Antengene Corporation (Antengene), has been granted conditional approval for marketing by the China National Medical Products Administration (NMPA) for XPOVIO® (selinexor).

December 17, 2021
·
12 min read
Biotech Bay

Redica Systems Announces $30M Series B Led by Savant Growth to Bring New Analytics and Compliance Platform to FDA-Regulated Life Sciences Companies

Redica Systems, a cloud-based data intelligence platform serving FDA-regulated industries, announced it has secured a $30 million Series B led by Savant Growth, with participation from existing investor Rock Creek Capital.

December 17, 2021
·
3 min read
Business

First Wave BioPharma Announces Adjournment of Annual Meeting

First Wave BioPharma, Inc., today announced that it has adjourned its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) in order to provide stockholders additional time within which to vote on all proposals.

December 17, 2021
·
2 min read
Drug Development

Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, today announced that it has received positive topline data from its Phase 1 clinical trial for AL001.

December 17, 2021
·
6 min read
Pharm Country

20n Bio Raises $3.3 Million in Series Seed Funding to Advance Computational Design of New Proteins for Therapeutics

20n Bio has raised a $3.3 million seed round led by BlueRun Ventures China.

December 17, 2021
·
3 min read